Literature DB >> 4050035

[Partial replacement of the pelvis with the hip joint and proximal femur. A possibility in tumor treatment].

G Dahmen, U Heise.   

Abstract

In cases of extensive destructive osteolytic processes in the pelvis and hip region, alloplastic replacement of a part of the pelvis with a total hip replacement and, if necessary, partial replacement of the femur, can represent a therapeutic alternative to hemipelvectomy for preserving the limb in the presence of malignancies; it offers the same degree of radicality in removing the affected bone and soft tissue while preserving the bone. This applies with regard both to primary malignant growths as well as extensive isolated metastases and aseptic osteolysis following multiple total replacement procedures. The partial pelvic prostheses, produced individually on the basis of roentgenograms, are adapted to a great degree intraoperatively and fixed with screws, locknuts, and Palacos, and if possible lined with autogenous bone. Where the defects are extensive the pubic bone of the unaffected side is incorporated in the stabilization. Experience gathered so far and follow-up examinations show that all patients regain full mobility and weight-bearing ability, with almost complete lack of complaints and adequate to good motility. This is demonstrated by examples.

Entities:  

Mesh:

Year:  1985        PMID: 4050035     DOI: 10.1055/s-2008-1045148

Source DB:  PubMed          Journal:  Z Orthop Ihre Grenzgeb        ISSN: 0044-3220


  3 in total

1.  [Mega cups and partial pelvic replacement].

Authors:  R von Eisenhart-Rothe; H Gollwitzer; A Toepfer; H Pilge; B M Holzapfel; H Rechl; R Gradinger
Journal:  Orthopade       Date:  2010-10       Impact factor: 1.087

2.  The gluteal approach to the ischium.

Authors:  J Bruns; G Dahmen
Journal:  Arch Orthop Trauma Surg       Date:  1986

3.  [Surgical treatment of osseous metastases of the pelvis].

Authors:  S Bading; E Mössinger; S Baus; L Bastian
Journal:  Unfallchirurg       Date:  2004-05       Impact factor: 1.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.